Caricamento...

Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer?

PURPOSE: Differential efficacy of newly registered therapies in subgroups of metastatic breast cancer (MBC) is an important consideration for subsequent use in clinical practice. Unfortunately, such subgroup analyses often are exploratory and rarely statistically adequately powered and may thus be m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Care (Basel)
Autori principali: Kolben, Thomas, Bardenhewer, Maximilian, Kolben, Theresa M., Rickerl, Laura, Degenhardt, Tom, Mahner, Sven, Harbeck, Nadia, Wuerstlein, Rachel
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger GmbH 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650101/
https://ncbi.nlm.nih.gov/pubmed/33223997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000504527
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !